carbamazepine essential pharma
essential pharma ltd - carbamazepine - suppositories - 125 milligram - carbamazepine
carbamazepine essential pharma
essential pharma ltd - carbamazepine - suppositories - 250 milligram - carbamazepine
dexamethasone kern pharma
mbi pharma ltd., israel - dexamethasone phosphate ( as sodium phosphate ) - solution for injection / infusion - dexamethasone phosphate ( as sodium phosphate ) 4 mg/ml - dexamethasone - dexamethasone kern pharma is indicated in the treatment of:• endocrine diseases such as nonsuppurative thyroiditis, hypercalcaemia associated with cancer and congenital adrenal hyperplasia.• allergy: severe or disabling allergic conditions resistant to conventional treatments, as in: bronchial asthma, contact or atopical dermatitis, seasonal or perennial allergic rhinitis, hypersensitivity reactions to drugs.• ophtalmic: serious inflammatory and allergic processes, acute and chronic, affecting the eyes, such as: iritis and iridocyclitis, chorioretinitis, choroiditis and diffuse posterior uveitis, optical neuritis, allergic conjunctivitis, allergic marginal corneal ulcers.• inflammatory bowel dis.: systemic treatment in exacerbations of ulcerative colitis and regional enteritis.• dermatological diseases (pemphigus, stevens johnson syndrome, exfoliative dermatitis, severe psoriasis and mycosis fungoides) • respiratory diseases (symptomatic sarcoidosis, berylliosis, loeffler's syndrome)• haematological: acquired )autoimmune( haemolytic anaemia, idiopathic thrombocytopenic purpura in adult, pure red cell aplasia• nephrotic syndrome of the idioplathic type or that due to lupus erythematosus• cerebral edema caused by brain tumor, neurosurgery, brain abscess, bacterial meningitis• collagen diseases: active rheumatoid arthritis with severe progressive course, fast destructive remitting forms and / or extra-articular manifestations, juvenile idiopathic arthritis with severe systemic-onset form (still's disease) or locally with no control, rheumatic fever with carditis, dermatomyositis, polymyositis, sle, temporal arteritis.• infectious diseases: bacterial meningitis – adjunct to antibiotics in suspected pneumococcal meningitis and tb meningitis. severe infectious diseases with toxic states (eg tuberculosis, typhoid, brucellosis;. only with simultaneous anti-infective therapy)• fetal lung maturation• chemotherapy – associated nausea and vomiting• multiple myeloma – part of chemotherapy protocols (eg vad)• prevention and treatment of acute mountain sickness/hace
dexamfetamine sulfate 1mg/ml oral solution
essential pharmaceuticals ltd - dexamfetamine sulfate - oral solution - 1mg/ml - psychoanaleptics; psychostimulants, agents used for adhd and nootropics; centrally acting sympathomimetics - it is indicated in the treatment of narcolepsy in adults
miacalcic 100 iu/ml solution for injection and infusion
essential pharma ltd - calcitonin, salmon - solution for injection/infusion - 100 international unit(s)/millilitre - calcitonin preparations; calcitonin (salmon synthetic)
miacalcic
essential pharma ltd - calcitonin, salmon - solution for inj/inf - 50 iu/ml - calcitonin (salmon synthetic)
slow k
essential pharma ltd - potassium chloride - tablet prolonged release - 600 milligram - potassium chloride
miacalcic ampoules solution for inj/inf 100iu/ml
essential pharma ltd 7 egham business village, crabtree road, egham, surrey, tw20 8rb , united kingdom - calcitonin, salmon - solution for injection - calcitonin, salmon 100 iu/ml - calcium homeostasis
pancrex v gastro-resistant tablets
essential pharmaceuticals ltd - amylase; lipase; protease - gastro-resistant tablet - 1700unit ; 1900unit ; 110unit
pancrex v oral powder
essential pharmaceuticals ltd - amylase; lipase; protease - powder - 30000unit ; 25000unit ; 1400unit